These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
278 related items for PubMed ID: 11805185
1. Open randomized trial comparing early withdrawal of either cyclosporine or mycophenolate mofetil in stable renal transplant recipients initially treated with a triple drug regimen. Schnuelle P, van der Heide JH, Tegzess A, Verburgh CA, Paul LC, van der Woude FJ, de Fijter JW. J Am Soc Nephrol; 2002 Feb; 13(2):536-543. PubMed ID: 11805185 [Abstract] [Full Text] [Related]
2. Cyclosporine withdrawal from a mycophenolate mofetil-containing immunosuppressive regimen in stable kidney transplant recipients: a randomized, controlled study. Abramowicz D, Manas D, Lao M, Vanrenterghem Y, Del Castillo D, Wijngaard P, Fung S, Cyclosporine Withdrawal Study Group. Transplantation; 2002 Dec 27; 74(12):1725-34. PubMed ID: 12499889 [Abstract] [Full Text] [Related]
3. Predictive factors of acute rejection after early cyclosporine withdrawal in renal transplant recipients who receive mycophenolate mofetil: results from a prospective, randomized trial. Hazzan M, Labalette M, Copin MC, Glowacki F, Provôt F, Pruv FR, Noël C. J Am Soc Nephrol; 2005 Aug 27; 16(8):2509-16. PubMed ID: 15987748 [Abstract] [Full Text] [Related]
4. Cyclosporine withdrawal from a mycophenolate mofetil-containing immunosuppressive regimen: results of a five-year, prospective, randomized study. Abramowicz D, Del Carmen Rial M, Vitko S, del Castillo D, Manas D, Lao M, Gafner N, Wijngaard P, Cyclosporine Withdrawal Study Group. J Am Soc Nephrol; 2005 Jul 27; 16(7):2234-40. PubMed ID: 15917338 [Abstract] [Full Text] [Related]
5. Mycophenolate mofetil for the prevention of acute rejection in primary cadaveric renal allograft recipients. U.S. Renal Transplant Mycophenolate Mofetil Study Group. Sollinger HW. Transplantation; 1995 Aug 15; 60(3):225-32. PubMed ID: 7645033 [Abstract] [Full Text] [Related]
6. Successful withdrawal of steroids in pediatric renal transplant recipients receiving cyclosporine A and mycophenolate mofetil treatment: results after four years. Höcker B, John U, Plank C, Wühl E, Weber LT, Misselwitz J, Rascher W, Mehls O, Tönshoff B. Transplantation; 2004 Jul 27; 78(2):228-34. PubMed ID: 15280683 [Abstract] [Full Text] [Related]
9. Early steroid withdrawal protocol with basiliximab, cyclosporine and mycophenolate mofetil in renal-transplant recipients. Kato Y, Tojimbara T, Iwadoh K, Koyama I, Nanmoku K, Kai K, Sannomiya A, Nakajima I, Fuchinoue S, Teraoka S. Int Immunopharmacol; 2006 Dec 20; 6(13-14):1984-92. PubMed ID: 17161352 [Abstract] [Full Text] [Related]
10. Everolimus with reduced cyclosporine versus MMF with standard cyclosporine in de novo heart transplant recipients. Lehmkuhl HB, Arizon J, Viganò M, Almenar L, Gerosa G, Maccherini M, Varnous S, Musumeci F, Hexham JM, Mange KC, Livi U, 2411 Study Investigators. Transplantation; 2009 Jul 15; 88(1):115-22. PubMed ID: 19584690 [Abstract] [Full Text] [Related]